Acrobiosystems Co Ltd
SZSE:301080
Acrobiosystems Co Ltd
Operating Expenses
Acrobiosystems Co Ltd
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Acrobiosystems Co Ltd
SZSE:301080
|
Operating Expenses
-ÂĄ367.2m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
N/A
|
||
Beigene Ltd
HKEX:6160
|
Operating Expenses
-ÂĄ23.5B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
||
Innovent Biologics Inc
HKEX:1801
|
Operating Expenses
-ÂĄ7.2B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
||
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Operating Expenses
-ÂĄ3.1B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
||
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Operating Expenses
-ÂĄ4.9B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-30%
|
||
Imeik Technology Development Co Ltd
SZSE:300896
|
Operating Expenses
-ÂĄ649m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
Acrobiosystems Co Ltd
Glance View
ACROBiosystems Co., Ltd. engages in the development of biomedicine and bio-protein technology. The company is headquartered in Beijing, Beijing and currently employs 397 full-time employees. The company went IPO on 2021-10-18. The firm's main products are recombinant proteins and detection services, as well as kits, antibodies, fillers, culture media and other related products. The firm's main products and services are applied to research and development (R&D) and production links such as early drug discovery and verification, drug screening and optimization, development and optimization of diagnostic reagents, preclinical and clinical trials, drug production process and process control (CMC) of tumors, autoimmune diseases, cardiovascular diseases, infectious diseases and other diseases.
See Also
What is Acrobiosystems Co Ltd's Operating Expenses?
Operating Expenses
-367.2m
CNY
Based on the financial report for Dec 31, 2023, Acrobiosystems Co Ltd's Operating Expenses amounts to -367.2m CNY.
What is Acrobiosystems Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-48%
Over the last year, the Operating Expenses growth was -33%. The average annual Operating Expenses growth rates for Acrobiosystems Co Ltd have been -61% over the past three years , -48% over the past five years .